𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Darbepoetin α for the treatment of anemia in patients with myelodysplastic syndromes

✍ Scribed by Pilar Giraldo; Benet Nomdedeu; Javier Loscertales; Carmen Requena; Raquel de Paz; Mar Tormo; Pilar Navarro; Patricia Benedit; José Antonio Gasquet; on behalf of the Aranesp in Myelodysplastic Syndromes (ARM) Study Group

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
295 KB
Volume
107
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of androgen therapy and anemia on
Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes
✍ Piedras, Josefa; Hernández, Guadalupe; López-Karpovitch, Xavier 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 2 views

Immunoreactive serum erythropoietin (EPO) was measured in anemic and non-anemic patients with acquired non-severe aplastic anemia (AA; n = 22) and myelodysplastic syndromes (MDS; n = 31) receiving or not androgens to examine the effect of androgen therapy and anemia on EPO levels in these disorders.

Red blood cell transfusions and iron ove
Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes
✍ Elias Jabbour; Hagop M. Kantarjian; Charles Koller; Ali Taher 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

## Abstract ## BACKGROUND Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year. ## METHODS The mainstay for the management of myelodysplastic syndromes (MDS) is supportive therapy with red blood cell (RBC) transfusions to improve the patie